Menu
GWAS Study

A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension.

Xiao X, Li R, Wu C et al.

36447229 PubMed ID
GWAS Study Type
1358 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

XX
Xiao X
LR
Li R
WC
Wu C
YY
Yan Y
YM
Yuan M
CB
Cui B
ZY
Zhang Y
ZC
Zhang C
ZX
Zhang X
ZW
Zhang W
HR
Hui R
WY
Wang Y
Chapter II

Abstract

Summary of the research findings

Compared with patients who require fewer antihypertensive agents, those with apparent treatment-resistant hypertension (aTRH) are at increased risk for cardiovascular and all-cause mortality, independent of blood pressure control. However, the etiopathogenesis of aTRH is still poorly elucidated.

556 Han Chinese ancestry cases, 802 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1358
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.